General Western Blot Reagents
Abcam Cysteamine hydrochloride, Degradation product of cystine, 100G
MW 113.61 Da, Purity >98%. Degradation product of cystine. Various pharmacological activities. Effective against cystinosis. Antitumor agent. Active in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam ACTH (1-24) (human), ACTH/MC2 receptor agonist, 500UG
MW 2933.4 Da. ACTH (1-24) (human), ACTH/MC2 receptor agonist. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Bezafibrate, Pan-PPAR agonist, 5G
MW 361.8 Da, Purity >99%. Pan-PPAR agonist (EC₅₀ values are 50, 60 and 20 μM at PPARα, PPARγ and PPARδ human receptors respectively). More efficient than fenofibrate (ab120832) in reducing body weight and blood glucose. Antidiabetic and antihyperlipidemic effects.
The product is subject to the following: Abcam Restricted Use Statement
Abcam SR 59230A hydrochloride, beta3 adrenoceptor antagonist, 10MG
MW 361.9 Da, Purity >99%. Potent, selective β3 adrenoceptor antagonist (IC50 values are 40, 408 and 648 nM for β3, β1 and β2, respectively). Orally active *in vivo*.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Nitrendipine, L-type Ca2+ channel blocker, 500MG
MW 360.4 Da, Purity >98%. L-type Ca2+ channel blocker. Antihypertensive *in vivo*. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam ICI 182,780, Estrogen receptor antagonist, 10MG
MW 606.8 Da, Purity >99%. Estrogen receptor antagonist with no partial agonist activity. Anticancer agent (IC₅₀ = 0.29 nM for inhibition of breast cancer cell growth). Causes downregulation and loss of estrogen receptors.
The product is subject to the following: Abcam Restricted Use Statement
Abcam alpha-Cyclode x trin, non-reducing cyclic saccharide, 5G
MW 972.86 g/mol. Non-reducing cyclic saccharide consisting of six α-1,4-linked D-glucopyranosyl units produced by the action of cyclodextrin glucosyltransferase (CGTase, EC 2.4.1.19) on hydrolyzed starch. Useful for the solubilization of nonpolar macromolecules such as fatty acids, lipids, and cholesterol for use in cell culture applications. Cyclodextrins are low molecular weight organic molecules which form water-soluble complexes with various compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam LM11A-31, nonpeptide p75NTR ligand, 5MG
MW 316.26 Da. Selective nonpeptide p75NTR ligand. Blocks p75-mediated cell death. Promotes neurogenesis and neurite survival. Does not affect NGF binding to TrkA. Shows neuroprotective and neuroregenerative effects *in vivo.* Orally active. Blood-brain barrier permeable.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Human Histone H3 (acetyl K27) peptide, 1MG
Human Histone H3 (acetyl K27) peptide is a Synthetic blocking peptide. >90% purity and suitable for Dot, BL.
Protein/ Peptide/ Enzyme Synonyms: H3FA, HIST1H3A, H3C2, H3FL, HIST1H3B, H3C3, H3FC HIST1H3C, H3C4, H3FB, HIST1H3D, H3C6, H3FD, HIST1H3E, H3C7, H3FI, HIST1H3F, H3C8, H3FH, HIST1H3G, H3C10, H3FK, HIST1H3H, H3C11, H3FF, HIST1H3I, H3C12, H3FJ, HIST1H3J, H3FC, HIST1H3C, H3C1, Histone H3.1, Histone H3/a, Histone H3/b, Histone H3/c, Histone H3/d, Histone H3/f, Histone H3/h, Histone H3/i, Histone H3/j, Histone H3/k, Histone H3/l, H3K27ac
Conjugation: Unconjugated
The product is subject to the following: Abcam Restricted Use Statement
Abcam Human NRG1 type III peptide, 1MG
Human NRG1 type III peptide is a Synthetic blocking peptide. Suitable for BL.
Protein/ Peptide/ Enzyme Synonyms: GGF, HGL, HRGA, NDF, SMDF, NRG1, Pro-NRG1
Conjugation: Unconjugated
The product is subject to the following: Abcam Restricted Use Statement
Abcam AMN082 dihydrochloride, mGlu7 agonist, 50MG
MW 465.5 Da, Purity >98%. Potent, selective, orally active and brain penetrant mGlu7 receptor agonist. Potently inhibits cAMP accumulation and stimulates GTP binding (EC50 = 64-290 nM) in mGluR7 transfected cells. Selective over mGlu1, 2, 3, 4,5, 6, and 8, ionotropic receptors (up to 10 μM). Elevates plasma stress hormones *in vivo*. Induces mGlu7 receptor internalisation in dissociated hippocampal neurones.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Native Chicken IgY protein
Native Chicken IgY protein is a Full Length protein, expressed in Native and with >=97% purity.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Concanamycin B, H+-ATPase inhibitor, 100UG
MW 852.1 Da, Purity >98%. Potent, selective vacuolar type H+-ATPase inhibitor. Antibiotic agent. Induces EGF-dependent apoptosis. Shows similar effects as Concanamycin A (ab144227) and Concanamycin C (ab144229). Shows potent antiviral effects (IC50 = 6 nM, HSV-1 replication).
The product is subject to the following: Abcam Restricted Use Statement
Abcam Concanamycin C, H+-ATPase inhibitor, 500UG
MW 823.1 Da, Purity >98%. Potent, selective vacuolar-type H+-ATPase inhibitor. Macrolide antibiotic agent. Concanamycin A (ab144227) analog. Shows antiproliferative and potent antifungal effects.
The product is subject to the following: Abcam Restricted Use Statement
Apexbio Technology LLC MDV3100 (Enzalutamide), 915087-33-1, MFCD14155804, 5 mg
MF: C21H16F4N4O2S, MW: 464.4, Synonyms: Enzalutamide, MDV3100, MDV-3100, MDV 3100. Solubility: 23.22mg/mL in DMSO. MDV3100, known as Enzalutamide, is a second-generation androgen receptor (AR) signaling inhibitor. It has been demonstrated impressive affinity to the AR compared to the first-generation AR inhibitors. It is able to inhibit binding of androgens to the AR, AR nuclear translocation, and the association of the AR with DNA.